FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2941101173> ?p ?o ?g. }

• W2941101173 abstract "Background PCSK9 (proprotein convertase subtilisin/kexin type 9) inhibitors effectively lower LDL (low‐density lipoprotein) cholesterol and have been shown to reduce cardiovascular outcomes in high‐risk patients. We used real‐world electronic health record data to characterize use of PCSK9 inhibitors, in addition to standard therapies, according to cardiovascular risk status. Methods and Results Data were obtained from 18 health systems with data marts within the National Patient‐Centered Clinical Research Network (PCORnet) using a common data model. Participating sites identified >17.5 million adults, of whom 3.6 million met study criteria. Patients were categorized into 3 groups: (1) dyslipidemia, (2) untreated LDL ≥130 mg/dL, and (3) coronary artery disease or coronary heart disease. Demographics, comorbidities, estimated 10‐year atherosclerotic cardiovascular disease risk, and lipid‐lowering pharmacotherapies were summarized for each group. Participants’ average age was 62 years, 50% were female, and 11% were black. LDL cholesterol ranged from 85 to 151 mg/dL. Among patients in groups 1 and 3, 54% received standard lipid‐lowering therapies and a PCSK9 inhibitor was prescribed in <1%. PCSK9 inhibitor prescribing was greatest for patients with coronary artery disease or coronary heart disease and, although prescribing increased during the study period, overall PCSK9 inhibitor prescribing was low. Conclusions We successfully used electronic health record data from 18 PCORnet data marts to identify >3.6 million patients meeting criteria for 3 patient groups. Approximately half of patients had been prescribed lipid‐lowering medication, but <1% were prescribed PCSK9 inhibitors. PCSK9 inhibitor prescribing increased over time for patients with coronary artery disease or coronary heart disease but not for those with dyslipidemia." @default.
• W2941101173 created "2019-05-03" @default.
• W2941101173 creator A5001429660 @default.
• W2941101173 creator A5012849300 @default.
• W2941101173 creator A5024109619 @default.
• W2941101173 creator A5030951014 @default.
• W2941101173 creator A5033296213 @default.
• W2941101173 creator A5034671525 @default.
• W2941101173 creator A5044494735 @default.
• W2941101173 creator A5054462484 @default.
• W2941101173 creator A5061196407 @default.
• W2941101173 creator A5062043780 @default.
• W2941101173 creator A5069427371 @default.
• W2941101173 creator A5070780364 @default.
• W2941101173 creator A5072564819 @default.
• W2941101173 creator A5086407394 @default.
• W2941101173 creator A5087519827 @default.
• W2941101173 creator A5088410308 @default.
• W2941101173 creator A5089000198 @default.
• W2941101173 date "2019-05-07" @default.
• W2941101173 modified "2023-10-16" @default.
• W2941101173 title "PCSK9 Inhibitor Use in the Real World: Data From the National Patient‐Centered Research Network" @default.
• W2941101173 cites W1520609538 @default.
• W2941101173 cites W1557163260 @default.
• W2941101173 cites W2019071303 @default.
• W2941101173 cites W2046181127 @default.
• W2941101173 cites W2096849439 @default.
• W2941101173 cites W2097092357 @default.
• W2941101173 cites W2164089346 @default.
• W2941101173 cites W2177226967 @default.
• W2941101173 cites W2247997571 @default.
• W2941101173 cites W2397518003 @default.
• W2941101173 cites W2511907480 @default.
• W2941101173 cites W2519956336 @default.
• W2941101173 cites W2580792129 @default.
• W2941101173 cites W2596179513 @default.
• W2941101173 cites W2599487612 @default.
• W2941101173 cites W2604674371 @default.
• W2941101173 cites W2604903590 @default.
• W2941101173 cites W2608952308 @default.
• W2941101173 cites W2613274125 @default.
• W2941101173 cites W2617335815 @default.
• W2941101173 cites W2756030371 @default.
• W2941101173 cites W2761079932 @default.
• W2941101173 cites W2766232664 @default.
• W2941101173 cites W2766569988 @default.
• W2941101173 cites W2767569336 @default.
• W2941101173 cites W2771919228 @default.
• W2941101173 cites W2790951009 @default.
• W2941101173 cites W2792168007 @default.
• W2941101173 doi "https://doi.org/10.1161/jaha.118.011246" @default.
• W2941101173 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6512121" @default.
• W2941101173 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31020929" @default.
• W2941101173 hasPublicationYear "2019" @default.
• W2941101173 type Work @default.
• W2941101173 sameAs 2941101173 @default.
• W2941101173 citedByCount "39" @default.
• W2941101173 countsByYear W29411011732019 @default.
• W2941101173 countsByYear W29411011732020 @default.
• W2941101173 countsByYear W29411011732021 @default.
• W2941101173 countsByYear W29411011732022 @default.
• W2941101173 countsByYear W29411011732023 @default.
• W2941101173 crossrefType "journal-article" @default.
• W2941101173 hasAuthorship W2941101173A5001429660 @default.
• W2941101173 hasAuthorship W2941101173A5012849300 @default.
• W2941101173 hasAuthorship W2941101173A5024109619 @default.
• W2941101173 hasAuthorship W2941101173A5030951014 @default.
• W2941101173 hasAuthorship W2941101173A5033296213 @default.
• W2941101173 hasAuthorship W2941101173A5034671525 @default.
• W2941101173 hasAuthorship W2941101173A5044494735 @default.
• W2941101173 hasAuthorship W2941101173A5054462484 @default.
• W2941101173 hasAuthorship W2941101173A5061196407 @default.
• W2941101173 hasAuthorship W2941101173A5062043780 @default.
• W2941101173 hasAuthorship W2941101173A5069427371 @default.
• W2941101173 hasAuthorship W2941101173A5070780364 @default.
• W2941101173 hasAuthorship W2941101173A5072564819 @default.
• W2941101173 hasAuthorship W2941101173A5086407394 @default.
• W2941101173 hasAuthorship W2941101173A5087519827 @default.
• W2941101173 hasAuthorship W2941101173A5088410308 @default.
• W2941101173 hasAuthorship W2941101173A5089000198 @default.
• W2941101173 hasBestOaLocation W29411011731 @default.
• W2941101173 hasConcept C126322002 @default.
• W2941101173 hasConcept C195910791 @default.
• W2941101173 hasConcept C2778096610 @default.
• W2941101173 hasConcept C2778163477 @default.
• W2941101173 hasConcept C2778213512 @default.
• W2941101173 hasConcept C2779134260 @default.
• W2941101173 hasConcept C2780072125 @default.
• W2941101173 hasConcept C2780745583 @default.
• W2941101173 hasConcept C2780902209 @default.
• W2941101173 hasConcept C2780948078 @default.
• W2941101173 hasConcept C43554185 @default.
• W2941101173 hasConcept C71924100 @default.
• W2941101173 hasConceptScore W2941101173C126322002 @default.
• W2941101173 hasConceptScore W2941101173C195910791 @default.
• W2941101173 hasConceptScore W2941101173C2778096610 @default.
• W2941101173 hasConceptScore W2941101173C2778163477 @default.
• W2941101173 hasConceptScore W2941101173C2778213512 @default.
• W2941101173 hasConceptScore W2941101173C2779134260 @default.
• W2941101173 hasConceptScore W2941101173C2780072125 @default.

• next